CLEVELAND CLEVELAND —
A woman so horribly disfigured she was willing to risk her life to do something about it has undergone the nation’s first near-total face transplant, the Cleveland Clinic announced yesterday.
Reconstructive surgeon Dr. Maria Siemionow and a team of other specialists replaced 80 percent of the woman’s face with that of a female cadaver a couple of weeks ago in a bold and contentious operation certain to stoke the debate over the ethics of such surgery.
The patient’s name and age were not released, and the hospital said her family wanted the reason for her transplant to remain confidential. The hospital plans a news conference today and would not give details until then.
The transplant was the fourth worldwide; two have been done in France, and one was performed in China.
Surgeons not connected to the Cleveland case reacted cautiously because little is known about the circ*mstances, but they generally praised the operation.
“There are patients who can benefit tremendously from this. It’s great that it happened,” said Dr. Bohdan Pomahac, a surgeon at Harvard-affiliated Brigham and Women’s Hospital in Boston who plans to offer face transplants, too.
Dr. Laurent Lantieri, a plastic surgeon at Henri Mondor-Albert Chenevier Hospital, near Paris, who did a face transplant on a man disfigured by a rare genetic disease, said: “This is very good news for all of us that doctors in the U.S. have done this.”
Unlike operations involving vital organs such as hearts and livers, transplants of faces or hands are done to improve quality of life – not extend it. Recipients run the risk of deadly complications and must take immune-suppressing drugs for the rest of their lives to prevent organ rejection, raising their odds of cancer and many other problems.
Arthur Caplan, a leading bioethicist who has expressed grave concerns in the past about such surgery, withheld judgment on the Cleveland case but said the woman’s doctors should give her the option of assisted suicide if they wind up making her life worse.
“The biggest ethical problem is dealing with failure – if your face rejects. It would be a living hell,” said Caplan, bioethics chief at the University of Pennsylvania. “If your face is falling off and you can’t eat and you can’t breathe and you’re suffering in a terrible manner that can’t be reversed, you need to put on the table assistance in dying.”
Siemionow’s long and careful preparation should help prevent such a horrific outcome, those familiar with her said. Siemionow, 58, a noted hand microsurgeon, has been testing the surgical approach and ways to temper the immune system’s response in experiments for more than a decade.
She has considered dozens of potential candidates over the past four years, ever since the clinic’s internal review board gave permission for her to attempt the operation, and has said she would choose someone severely disfigured as her first case.
“She’s a leader in this field. She’s been investigating this for a long time. She has done the most amount of research in small animals looking at this,” said Dr. Warren Breidenbach, a surgeon at Jewish Hospital in Louisville, Ky., who in 1999 did the nation’s first hand transplant. Siemionow trained with him in Louisville.
The world’s first partial face transplant was performed in France in 2005 on a 38-year-old woman who had been mauled by her dog. Isabelle Dinoire received a new nose, chin and lips from a brain-dead donor. She has done so astoundingly well that surgeons have become more comfortable with a radical operation considered unthinkable a decade ago.
Two others have received partial face transplants since then – a Chinese farmer attacked by a bear and a European man disfigured by a genetic condition. Both are believed to be doing well, though details, especially of the Chinese case, have been scant.
Details of the Cleveland surgery are not known, but surgeons generally transplant skin, facial nerves and muscle, and often other deep tissue. That is done so the new face will actually function and not just be a mask.
In an interview at the Cleveland Clinic in 2005, Siemionow spoke of the terrible need she saw in people horribly disfigured and how badly it scarred their social and emotional lives, not just their bodies. “There are no really good alternative therapies for the severely burned or patients with a facial injury or damage,” she said.
Her task now is to prevent organ rejection while managing the risk of infection from taking strong immune-suppressing drugs.
Rejection is a possibility whenever someone receives an organ or cells from someone else because the body regards this as foreign tissue. Two types of problems can result.
The first is graft-versus-host disease, which could happen if the new facial tissue were to attack the recipient’s body. The second is if the patient’s body were to attack the transplanted face, causing inflammation and other problems at the site of the new tissue.
Either of these can be life-threatening. They can come on suddenly, within days or weeks of the operation, or set in slowly.
